Rerefined model
PDB 6DCG|dpdb_lwz0pxhb
Rerefined model
Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
- Program
- PHENIX 2.0_5824
- Model type
- Multiconformer
- Purpose
- Refinement
- Atoms
- 3,141
- Residues
- 326
- Protein chains
- 1
- Alternate-location fraction
- 0.92%
- Ligands
- G67, SO4
Evaluations
R-work
0.194
R-free
0.230
Clashscore
4.9
Macromolecules
The same in every model of this entry.
Data
L0 Raw
L1 Processed
L2 Models
L3 Evaluations